Dr. Shuvolina Mukherjee is a cancer proteomics researcher currently affiliated with the Department of Immunotechnology, Lund University. She is currently working on identifying diagnostic and prognostic markers from ovarian cancer cohort.
She has done her PhD from the Indian Institute of Technology, Bombay (IIT Bombay) where she worked on a collaborative project with the Tata Memorial Centre, Mumbai for identifying patient-specific global proteomic profile as well as PTMs in meningioma patients. During her career she has also been awarded the prestigious Newton-Bhabha fellowship via which she visited the Imperial College London and worked on patient derived primary cell lines for understanding abberated signalling cascades in meningiomas.
Dr. Shuvolina Mukherjee is a cancer proteomics researcher currently affiliated with the Department of Immunotechnology, Lund University. She is currently working on identifying diagnostic and prognostic markers from ovarian cancer cohort.
She has done her PhD from the Indian Institute of Technology, Bombay (IIT Bombay) where she worked on a collaborative project with the Tata Memorial Centre, Mumbai for identifying patient-specific global proteomic profile as well as PTMs in meningioma patients. During her career she has also been awarded the prestigious Newton-Bhabha fellowship via which she visited the Imperial College London and worked on patient derived primary cell lines for understanding abberated signalling cascades in meningiomas.